TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK
Soluble tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK), in contrast to membrane TWEAK and TNF, is only a weak activator of the classical NFκB pathway. We observed that soluble TWEAK was regularly more potent than TNF with respect to the induction of TNF receptor-associated factor...
Main Authors: | Carmona Arana, José Antonio, Seher, Axel, Neumann, Manfred, Lang, Isabell, Siegmund, Daniela, Wajant, Harald |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Media S.A.
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927163/ |
Similar Items
-
Exogenous Administration of a Recombinant Variant of TWEAK Impairs Healing after Myocardial Infarction by Aggravation of Inflammation
by: Pachel, Christina, et al.
Published: (2013) -
Principles of antibody-mediated TNF receptor activation
by: Wajant, H
Published: (2015) -
Reduced soluble TNF-like weak inducer of apoptosis (sTWEAK) and increased frap in postmenopausal women with metabolic syndrome
by: Comim, Fabio Vasconcellos, et al.
Published: (2015) -
TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling
by: Daniela Siegmund, et al.
Published: (2018-09-01) -
Soluble TWEAK independently predicts atherosclerosis in renal transplant patients
by: Turkmen, Kultigin, et al.
Published: (2013)